skip to content

Department of Chemistry


I joined the group in 2018 through the BBSRC DTP iCASE program with Eli Lilly, after completing the MChem/BSc in Chemistry at the University of Leeds, including a year in industry at Optibrium Ltd.

The aim of my research is to develop methods to better understand the mechanism of action of drugs using biological data (such as transcriptomics data), for e.g. repurposing or target deconvolution following phenotypic screening. This includes the use of systems biology approaches such as causal reasoning on PPI (protein-protein interaction) networks to identify upstream protein perturbations leading to observed compound-induced gene expression changes.


Research Group

Telephone number

01223 336432

Email address